Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS; ASX: UNS), a developer and supplier of injectable drug delivery systems, today announced an acceleration of investments in manufacturing capacity, R&D, and...
Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS; ASX: UNS), a developer and supplier of injectable drug delivery systems, today announced an acceleration of investments in manufacturing capacity, R&D, and...
CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac and vascular surgery, announced today that its Board of Directors has approved a quarterly cash dividend for the third...
CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac and vascular surgery, announced today that its Board of Directors has approved a quarterly cash dividend for the third...
In conjunction with DURECT Corporation's (Nasdaq: DRRX) second quarter 2014 financial results press release, you are invited to listen to the conference call that will be broadcast live over the internet on Thursday,...
In conjunction with DURECT Corporation's (Nasdaq: DRRX) second quarter 2014 financial results press release, you are invited to listen to the conference call that will be broadcast live over the internet on Thursday,...
Endo International plc (NASDAQ: ENDP) (TSX: ENL) today announced the appointment of Shane M. Cooke to the company's board of directors. Mr. Cooke, an international business leader with more than 25 years of...
Endo International plc (NASDAQ: ENDP) (TSX: ENL) today announced the appointment of Shane M. Cooke to the company's board of directors. Mr. Cooke, an international business leader with more than 25 years of...
Synageva BioPharma Corp. ("Synageva") (NASDAQ: GEVA), a biopharmaceutical company developing therapeutic products for rare disorders, today reported second quarter 2014 financial results, and provided other business updates.
Synageva BioPharma Corp. ("Synageva") (NASDAQ: GEVA), a biopharmaceutical company developing therapeutic products for rare disorders, today reported second quarter 2014 financial results, and provided other business updates.
Cepheid (Nasdaq: CPHD) today announced that its group purchasing contract with Premier will end on September 30, 2014. Customers currently purchasing through the Premier GPO will be able to continue their relationship...
Cepheid (Nasdaq: CPHD) today announced that its group purchasing contract with Premier will end on September 30, 2014. Customers currently purchasing through the Premier GPO will be able to continue their relationship...
Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that it will report financial results and highlights...
Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that it will report financial results and highlights...
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi (EURONEXT: SAN and NYSE: SNY) today announced that the Companies intend to use a U.S. Food and Drug Administration (FDA) rare pediatric disease priority review...
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi (EURONEXT: SAN and NYSE: SNY) today announced that the Companies intend to use a U.S. Food and Drug Administration (FDA) rare pediatric disease priority review...
Hologic, Inc. (NASDAQ: HOLX) today announced its results for the third fiscal quarter ended June 28, 2014.
Hologic, Inc. (NASDAQ: HOLX) today announced its results for the third fiscal quarter ended June 28, 2014.
The Board of Directors of the Academy of Managed Care Pharmacy (AMCP) last evening expressed support for the "Pharmacists' Patient Care Process" recently developed by the Joint Commission of Pharmacy Practitioners...
The Board of Directors of the Academy of Managed Care Pharmacy (AMCP) last evening expressed support for the "Pharmacists' Patient Care Process" recently developed by the Joint Commission of Pharmacy Practitioners...
The Buoniconti Fund to Cure Paralysis will present the 29th Annual Great Sports Legends Dinner at the Waldorf Astoria on Monday, September 29, 2014. The annual event, hosted by NFL Hall of Famer Nick Buoniconti and his son...
The Buoniconti Fund to Cure Paralysis will present the 29th Annual Great Sports Legends Dinner at the Waldorf Astoria on Monday, September 29, 2014. The annual event, hosted by NFL Hall of Famer Nick Buoniconti and his son...
In response to the 106,782 signatures collected through TheRacetoYes.Org petition urging the "FDA to Say Yes to Accelerated Approval for safe, effective therapies for children with Duchenne" muscular dystrophy, the White...
In response to the 106,782 signatures collected through TheRacetoYes.Org petition urging the "FDA to Say Yes to Accelerated Approval for safe, effective therapies for children with Duchenne" muscular dystrophy, the White...
Harley-Davidson Authorized Rentals, the world's largest motorcycle rentals provider, is joining with world renowned skincare company Kiehl's Since 1851 as the exclusive motorcycle partner and Gold Sponsor of the...
Harley-Davidson Authorized Rentals, the world's largest motorcycle rentals provider, is joining with world renowned skincare company Kiehl's Since 1851 as the exclusive motorcycle partner and Gold Sponsor of the...
Thanks to advances in minimally invasive surgery, pain management, preoperative preparation and rapid rehabilitation methods, patients of Dr. Craig McAllister at EvergreenHealth in Kirkland, Washington, can now receive...
Thanks to advances in minimally invasive surgery, pain management, preoperative preparation and rapid rehabilitation methods, patients of Dr. Craig McAllister at EvergreenHealth in Kirkland, Washington, can now receive...
Mike Fallon and Fedor Steer, AKA CareFit, announce their first Open Enrollment in search of the best caregivers in Collier and Lee counties to join their e-portfolio caregiving program.
Mike Fallon and Fedor Steer, AKA CareFit, announce their first Open Enrollment in search of the best caregivers in Collier and Lee counties to join their e-portfolio caregiving program.
Telligen, Inc., a leader in population health management solutions, has been awarded the Centers for Medicare & Medicaid Services (CMS) Quality Innovation Network Quality Improvement Organization (QIN-QIO) contract for...
Telligen, Inc., a leader in population health management solutions, has been awarded the Centers for Medicare & Medicaid Services (CMS) Quality Innovation Network Quality Improvement Organization (QIN-QIO) contract for...
PuraMed BioScience®, Inc., (OTCPink:PMBS), a researcher, developer, and marketer of over-the-counter (OTC) medicinal and healthcare products, announced today that the company is rebranding the LipiGesic® M name along with...
PuraMed BioScience®, Inc., (OTCPink:PMBS), a researcher, developer, and marketer of over-the-counter (OTC) medicinal and healthcare products, announced today that the company is rebranding the LipiGesic® M name along with...
Analysts with Great American Group, Inc. (OTCBB: GAMR) report that as the healthcare industry continues to undergo unprecedented changes, including reforms of the Affordable Care Act ("ACA"), wider consumer choice, public...
Analysts with Great American Group, Inc. (OTCBB: GAMR) report that as the healthcare industry continues to undergo unprecedented changes, including reforms of the Affordable Care Act ("ACA"), wider consumer choice, public...
Today the US Surgeon General issued the most stern warning to date for indoor and outdoor sun tanning or sun burns stating they can lead directly to deadly melanoma skin cancer. In his statement Surgeon, General Boris...
Today the US Surgeon General issued the most stern warning to date for indoor and outdoor sun tanning or sun burns stating they can lead directly to deadly melanoma skin cancer. In his statement Surgeon, General Boris...
Research and Markets has announced the addition of the "Hematology Analyzers & Reagents Market - Forecasts to 2019" report to their offering.
Research and Markets has announced the addition of the "Hematology Analyzers & Reagents Market - Forecasts to 2019" report to their offering.
Decision Resources Group finds that the majority of surveyed pharmacy and medical directors in the United States believe that the key drivers of biosimilar market penetration will be the level of savings achievable by...
Decision Resources Group finds that the majority of surveyed pharmacy and medical directors in the United States believe that the key drivers of biosimilar market penetration will be the level of savings achievable by...
El Camino Hospital, a leader in the use of technology to improve patient care, is utilizing the Leaf Patient Monitoring system to help prevent hospital-acquired pressure ulcers by monitoring the position and movement of...
El Camino Hospital, a leader in the use of technology to improve patient care, is utilizing the Leaf Patient Monitoring system to help prevent hospital-acquired pressure ulcers by monitoring the position and movement of...
A study presented at the 2014 World Transplant Congress evaluated the safety and efficacy of CSL Behring's C1 Inhibitor (C1-INH) concentrate in preventing antibody-mediated rejection following kidney transplants in...
A study presented at the 2014 World Transplant Congress evaluated the safety and efficacy of CSL Behring's C1 Inhibitor (C1-INH) concentrate in preventing antibody-mediated rejection following kidney transplants in...
Ascension, the nation's largest Catholic and non-profit health system, today announced the formation of Ascension Health Senior Care, uniting the majority of its senior-focused programs into one national organization.
Ascension, the nation's largest Catholic and non-profit health system, today announced the formation of Ascension Health Senior Care, uniting the majority of its senior-focused programs into one national organization.
Joe Ostaszewski, Biggest Loser finalist and former Florida State University defensive lineman, says the Biggest Loser show saved his life. Now, he's "riding it forward" in a 2,900-mile bike ride across the country to...
Joe Ostaszewski, Biggest Loser finalist and former Florida State University defensive lineman, says the Biggest Loser show saved his life. Now, he's "riding it forward" in a 2,900-mile bike ride across the country to...
Decision Resources Group finds that the United States preclinical animal research imaging system market will be significantly driven by the trend toward multimodality imaging, such as combining computed tomography and...
Decision Resources Group finds that the United States preclinical animal research imaging system market will be significantly driven by the trend toward multimodality imaging, such as combining computed tomography and...
Reportlinker.com announces that a new market research report is available in its catalogue: mHealth and Home Monitoring – 6th Edition http://www.reportlinker.com/p0356852/mHealth-and-Home-Monitoring-–-6th-Edition.html
Reportlinker.com announces that a new market research report is available in its catalogue: mHealth and Home Monitoring – 6th Edition http://www.reportlinker.com/p0356852/mHealth-and-Home-Monitoring-–-6th-Edition.html
Research and Markets has announced the addition of the "Global and Chinese Aseptic Packaging Industry Report 2014" report to their offering.
Research and Markets has announced the addition of the "Global and Chinese Aseptic Packaging Industry Report 2014" report to their offering.
Replikins Ltd. today released new data on changes in the gene structure of the Ebola virus. Before the current outbreaks, the mean Ebola Reston gene Replikin Count (number of Replikins per 100 amino acids) between 1995 and...
Replikins Ltd. today released new data on changes in the gene structure of the Ebola virus. Before the current outbreaks, the mean Ebola Reston gene Replikin Count (number of Replikins per 100 amino acids) between 1995 and...
InnoPharma, Inc. today announced the first generic launch of Olanzapine for Injection, 10mg/vial (the generic equivalent of Zyprexa® injection), in Canada. Olanzapine is indicated for the rapid control of agitation and...
InnoPharma, Inc. today announced the first generic launch of Olanzapine for Injection, 10mg/vial (the generic equivalent of Zyprexa® injection), in Canada. Olanzapine is indicated for the rapid control of agitation and...
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Galectin Therapeutics, Inc. ("Galectin Therapeutics" or the "Company")...
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Galectin Therapeutics, Inc. ("Galectin Therapeutics" or the "Company")...
Decision Resources Group finds that the United States clot management device market will expand through 2022, particularly in the later years. This will be primarily as a result of increasing uptake of neurovascular...
Decision Resources Group finds that the United States clot management device market will expand through 2022, particularly in the later years. This will be primarily as a result of increasing uptake of neurovascular...
Pharmacy is not Antonio Silva's first career, but he is certain it will be his last. In the past, the 34-year-old Riverside, California, resident has served in the U.S. Marine Corps and owned and operated his own small...
Pharmacy is not Antonio Silva's first career, but he is certain it will be his last. In the past, the 34-year-old Riverside, California, resident has served in the U.S. Marine Corps and owned and operated his own small...
Unique Pizza and Subs Corporation ("Unique," OTC Markets Groups Inc.: OTC Pink: UPZS), a Delaware Corporation, is pleased to announce it has signed a distribution agreement with Larasan Pharmaceutical Corporation...
Unique Pizza and Subs Corporation ("Unique," OTC Markets Groups Inc.: OTC Pink: UPZS), a Delaware Corporation, is pleased to announce it has signed a distribution agreement with Larasan Pharmaceutical Corporation...
Valeant Pharmaceuticals North America LLC, today announced the 2014 winners of the Second annual I Acanya® Succeed scholarship program, an education-based initiative that rewards college students for taking a proactive...
Valeant Pharmaceuticals North America LLC, today announced the 2014 winners of the Second annual I Acanya® Succeed scholarship program, an education-based initiative that rewards college students for taking a proactive...
DigiPath, Inc. (OTCBB and OTCQB: DIGP), a digital pathology solution provider that is expanding into the cannabis testing and education markets, announced today that has been no material development in its business and...
DigiPath, Inc. (OTCBB and OTCQB: DIGP), a digital pathology solution provider that is expanding into the cannabis testing and education markets, announced today that has been no material development in its business and...
The MedMen, the first and leading consulting and management firm in the marijuana industry, is proud to announce the appointment of Dr. Duke Fu as President of the company after leaving behind five years of indispensable...
The MedMen, the first and leading consulting and management firm in the marijuana industry, is proud to announce the appointment of Dr. Duke Fu as President of the company after leaving behind five years of indispensable...
Researchers often use microelectronic devices embedded with biological components to interrogate biology, but such devices can do much more – perhaps even control biology.
Researchers often use microelectronic devices embedded with biological components to interrogate biology, but such devices can do much more – perhaps even control biology.
Chicagoland Speedway today announced Janssen Pharmaceuticals, Inc., the official cardiovascular partner of NASCAR®, as the title sponsor of this year's first Chase for the NASCAR Sprint Cup™ race. The MyAFibStory.com...
Chicagoland Speedway today announced Janssen Pharmaceuticals, Inc., the official cardiovascular partner of NASCAR®, as the title sponsor of this year's first Chase for the NASCAR Sprint Cup™ race. The MyAFibStory.com...
ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), a developer of new products for oncology supportive care, announced that its novel product for oral mucositis, MuGard®, has been featured in an article on OncLive.com titled,...
ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), a developer of new products for oncology supportive care, announced that its novel product for oral mucositis, MuGard®, has been featured in an article on OncLive.com titled,...
Lightlake Therapeutics Inc. ("Lightlake") (OTCQB: LLTP), a biopharmaceutical company developing addiction treatments based on its expertise in opioid antagonists, announced today that it has received a funding commitment...
Lightlake Therapeutics Inc. ("Lightlake") (OTCQB: LLTP), a biopharmaceutical company developing addiction treatments based on its expertise in opioid antagonists, announced today that it has received a funding commitment...
Cynosure, Inc. (NASDAQ: CYNO), a leader in laser- and light-based aesthetic treatments for non-invasive and minimally invasive applications, today announced that the Board of Directors has promoted Executive Vice...
Cynosure, Inc. (NASDAQ: CYNO), a leader in laser- and light-based aesthetic treatments for non-invasive and minimally invasive applications, today announced that the Board of Directors has promoted Executive Vice...
On Tuesday, July 29, 2014, the NASDAQ Composite ended at 4,442.70, down 0.05%, the Dow Jones Industrial Average finished the day 0.42% lower at 16,912.11, and the S&P 500 closed at 1,969.95, down 0.45%. The losses were...
On Tuesday, July 29, 2014, the NASDAQ Composite ended at 4,442.70, down 0.05%, the Dow Jones Industrial Average finished the day 0.42% lower at 16,912.11, and the S&P 500 closed at 1,969.95, down 0.45%. The losses were...
Skyline Urology Chief Medical Officer Dr. Richard David has been named Clinical Professor of Urology, Voluntary at the David Geffen School of Medicine at UCLA.
Skyline Urology Chief Medical Officer Dr. Richard David has been named Clinical Professor of Urology, Voluntary at the David Geffen School of Medicine at UCLA.
invendo medical GmbH, manufacturer and distributor of a single use and computer-assisted ("robotic") colonoscopy system, today announced the appointment of Nachum (Homi) Shamir, a worldwide recognized medical device...
invendo medical GmbH, manufacturer and distributor of a single use and computer-assisted ("robotic") colonoscopy system, today announced the appointment of Nachum (Homi) Shamir, a worldwide recognized medical device...
Packaging Coordinators, Inc. (PCI) is pleased to announce it has reached a definitive agreement to acquire Penn Pharmaceutical Services Limited (Penn Pharma). Penn Pharma is headquartered in Tredegar, Wales in the United...
Packaging Coordinators, Inc. (PCI) is pleased to announce it has reached a definitive agreement to acquire Penn Pharmaceutical Services Limited (Penn Pharma). Penn Pharma is headquartered in Tredegar, Wales in the United...
Research and Markets has announced the addition of the "Global Retinal Vein Occlusion Market 2014-2018" report to their offering.
Research and Markets has announced the addition of the "Global Retinal Vein Occlusion Market 2014-2018" report to their offering.
Do you currently take a vitamin D supplement? New research says you should. A study conducted by USANA Health Sciences, in conjunction with Intermountain Healthcare's The Orthopedic Specialty Hospital (TOSH), found...
Do you currently take a vitamin D supplement? New research says you should. A study conducted by USANA Health Sciences, in conjunction with Intermountain Healthcare's The Orthopedic Specialty Hospital (TOSH), found...
Perrigo Company (NYSE: PRGO;TASE) announced that it has filed with the U.S. Food and Drug Administration (FDA) an Abbreviated New Drug Application for desoximetasone topical spray 0.25% and that it has notified Taro...
Perrigo Company (NYSE: PRGO;TASE) announced that it has filed with the U.S. Food and Drug Administration (FDA) an Abbreviated New Drug Application for desoximetasone topical spray 0.25% and that it has notified Taro...
Stryker brand ambassadors Fred Funk and Hal Sutton are playing this week at the 3M Championship Champions Tour event near Minneapolis, MN, which begins Friday at TPC Twin Cities, in Blaine. Stryker is the official joint...
Stryker brand ambassadors Fred Funk and Hal Sutton are playing this week at the 3M Championship Champions Tour event near Minneapolis, MN, which begins Friday at TPC Twin Cities, in Blaine. Stryker is the official joint...
Silicon Valley Bank, the bank of the global innovation economy, released a study today that examines the merger, acquisition and IPO activity of private, venture-backed biopharma and medical device companies. According to...
Silicon Valley Bank, the bank of the global innovation economy, released a study today that examines the merger, acquisition and IPO activity of private, venture-backed biopharma and medical device companies. According to...
RapidArc® Radiosurgery can be used to deliver treatments for multiple brain metastases that are substantially less time consuming and comparable in quality to Gamma Knife® (GK) treatments, according to a new research study...
RapidArc® Radiosurgery can be used to deliver treatments for multiple brain metastases that are substantially less time consuming and comparable in quality to Gamma Knife® (GK) treatments, according to a new research study...
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven weight-loss products and programs, is proud to announce a new line of products available in its Take Shape For Life...
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven weight-loss products and programs, is proud to announce a new line of products available in its Take Shape For Life...
Syndax Pharmaceuticals, Inc. today announced that newly published results demonstrate that in preclinical studies entinostat significantly improved treatment outcomes in mouse tumor models when combined with anti-PD1 and...
Syndax Pharmaceuticals, Inc. today announced that newly published results demonstrate that in preclinical studies entinostat significantly improved treatment outcomes in mouse tumor models when combined with anti-PD1 and...
PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that management will present a company update at the Wedbush Life Sciences Management Access Conference on Tuesday, August 12th at 4:15 pm ET at the Le Parker Meridien...
PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that management will present a company update at the Wedbush Life Sciences Management Access Conference on Tuesday, August 12th at 4:15 pm ET at the Le Parker Meridien...
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi (EURONEXT: SAN and NYSE: SNY) today announced that nine new Phase 3 ODYSSEY trials of alirocumab in people with hypercholesterolemia met their primary efficacy...
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi (EURONEXT: SAN and NYSE: SNY) today announced that nine new Phase 3 ODYSSEY trials of alirocumab in people with hypercholesterolemia met their primary efficacy...
Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that nine new Phase 3 ODYSSEY trials of alirocumab in people with hypercholesterolemia met their primary efficacy...
Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that nine new Phase 3 ODYSSEY trials of alirocumab in people with hypercholesterolemia met their primary efficacy...
GenSpera, Inc. (OTCQB: GNSZ), a leader in developing prodrug therapeutics for the treatment of cancer, announces the issuance of a United States patent entitled "Methods and compositions for the detection of cancer". The...
GenSpera, Inc. (OTCQB: GNSZ), a leader in developing prodrug therapeutics for the treatment of cancer, announces the issuance of a United States patent entitled "Methods and compositions for the detection of cancer". The...
Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced a positive written response from the FDA in regards to the company's plans to begin production of AmpionTM in our new drug manufacturing facility.
Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced a positive written response from the FDA in regards to the company's plans to begin production of AmpionTM in our new drug manufacturing facility.
Orexigen Therapeutics, Inc. (Nasdaq: OREX) today announced it has received the Day 180 List of Outstanding Issues (LOI) from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) for the...
Orexigen Therapeutics, Inc. (Nasdaq: OREX) today announced it has received the Day 180 List of Outstanding Issues (LOI) from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) for the...
Eisai Inc. and Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that an article based on post-hoc analyses from the three pivotal Phase 3 trials of lorcaserin entitled, "Early Weight Loss While on Lorcaserin,...
Eisai Inc. and Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that an article based on post-hoc analyses from the three pivotal Phase 3 trials of lorcaserin entitled, "Early Weight Loss While on Lorcaserin,...
Adeptus Health Inc. (NYSE: ADPT) ("ADPT" or the "Company") announced its results for the second quarter ended June 30, 2014. All comparisons included in this release are for the second quarter 2014 to the second quarter...
Adeptus Health Inc. (NYSE: ADPT) ("ADPT" or the "Company") announced its results for the second quarter ended June 30, 2014. All comparisons included in this release are for the second quarter 2014 to the second quarter...
Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today reported results for the second quarter ended June 30, 2014. Net sales for the quarter were $1.1 billion and...
Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today reported results for the second quarter ended June 30, 2014. Net sales for the quarter were $1.1 billion and...
Gopika was born against all the odds in an area of India where foeticide is prevalent. Hailing from Ponamalai Nagar, a village in the Salem district of Andhra Pradesh, her family cherished their daughter, taking the utmost...
Gopika was born against all the odds in an area of India where foeticide is prevalent. Hailing from Ponamalai Nagar, a village in the Salem district of Andhra Pradesh, her family cherished their daughter, taking the utmost...
In conjunction with its second quarter 2014 earnings release (expected to be issued after market close on July 29, 2014), Covance Inc. (NYSE: CVD) is pleased to invite you to listen to its quarterly investor conference...
In conjunction with its second quarter 2014 earnings release (expected to be issued after market close on July 29, 2014), Covance Inc. (NYSE: CVD) is pleased to invite you to listen to its quarterly investor conference...
Bluegrass Vascular Technologies, a private medical technology company focused on innovating lifesaving devices and methods for vascular access, today announced it has closed $4.5 million in Series A financing, which was...
Bluegrass Vascular Technologies, a private medical technology company focused on innovating lifesaving devices and methods for vascular access, today announced it has closed $4.5 million in Series A financing, which was...
RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies,...
RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies,...
PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that company management will participate in the Jefferies 2014 Boston Healthcare Summit next week in Boston, Massachusetts. The conference will occur on August 6,...
PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that company management will participate in the Jefferies 2014 Boston Healthcare Summit next week in Boston, Massachusetts. The conference will occur on August 6,...
AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announces that its partner,...
AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announces that its partner,...
The T.J. Martell Foundation for Leukemia, Cancer and AIDS Research has announced the honorees for its 39th Annual Honors Gala on Tuesday, October 21, 2014 which will be held at the legendary Cipriani in New York. The...
The T.J. Martell Foundation for Leukemia, Cancer and AIDS Research has announced the honorees for its 39th Annual Honors Gala on Tuesday, October 21, 2014 which will be held at the legendary Cipriani in New York. The...
Medical Equipment Solutions, Corp. are pleased to announce that they have been awarded a Department of Defense (US Army) contract valued at over $2 million over 30 months to supply a mobile MRI diagnostic machine and...
Medical Equipment Solutions, Corp. are pleased to announce that they have been awarded a Department of Defense (US Army) contract valued at over $2 million over 30 months to supply a mobile MRI diagnostic machine and...
Epic Sciences, Inc. ("Epic"), a privately held biotech company that designs and develops novel diagnostics to personalize and advance the treatment and management of cancer, announced today the completion of a $30 million...
Epic Sciences, Inc. ("Epic"), a privately held biotech company that designs and develops novel diagnostics to personalize and advance the treatment and management of cancer, announced today the completion of a $30 million...
Epic Sciences, Inc. ("Epic"), a private biotech company that designs and develops novel diagnostics to personalize and advance the treatment and management of cancer, announced today the appoint of Gregory T. Lucier as...
Epic Sciences, Inc. ("Epic"), a private biotech company that designs and develops novel diagnostics to personalize and advance the treatment and management of cancer, announced today the appoint of Gregory T. Lucier as...
Intouch Solutions®, a marketing agency servicing the pharmaceutical industry, announced the availability of SocialQueue. SocialQueue gives pharma companies a new tool to easily monitor and manage activity across their...
Intouch Solutions®, a marketing agency servicing the pharmaceutical industry, announced the availability of SocialQueue. SocialQueue gives pharma companies a new tool to easily monitor and manage activity across their...
Company expands reach of latest GPU technology and CUDA programming expertise to big data, aerospace and defense, medical, and industrial, among other markets eInfochips, a leading engineering R&D services company,...
Company expands reach of latest GPU technology and CUDA programming expertise to big data, aerospace and defense, medical, and industrial, among other markets eInfochips, a leading engineering R&D services company,...
Immune Pharmaceuticals Inc. (OTCQX and NASDAQ OMX First North Premier, Stockholm: "IMNP."; "Immune" or "the Company") announces today that it has initiated the screening of patients for a Phase II proof of concept clinical...
Immune Pharmaceuticals Inc. (OTCQX and NASDAQ OMX First North Premier, Stockholm: "IMNP."; "Immune" or "the Company") announces today that it has initiated the screening of patients for a Phase II proof of concept clinical...
EDG Partners today announced a growth equity investment in MMIS, Inc. (MMIS), a global technology company that develops and markets compliance and collaboration software solutions for pharmaceutical and medical device...
EDG Partners today announced a growth equity investment in MMIS, Inc. (MMIS), a global technology company that develops and markets compliance and collaboration software solutions for pharmaceutical and medical device...
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has approved EYLEA® (aflibercept) Injection for the treatment of Diabetic Macular Edema (DME). The...
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has approved EYLEA® (aflibercept) Injection for the treatment of Diabetic Macular Edema (DME). The...
Amgen (NASDAQ: AMGN) today announced financial results for the second quarter of 2014. Key results include:
Amgen (NASDAQ: AMGN) today announced financial results for the second quarter of 2014. Key results include:
Express Scripts Holding Company (Nasdaq: ESRX) announced 2014 second quarter net income attributable to Express Scripts stockholders of $515.2 million, or $0.67 per diluted share. Adjusted earnings per diluted share, as...
Express Scripts Holding Company (Nasdaq: ESRX) announced 2014 second quarter net income attributable to Express Scripts stockholders of $515.2 million, or $0.67 per diluted share. Adjusted earnings per diluted share, as...
Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today that it is participating in two healthcare conferences during the third quarter, the 2014 Avondale Partners Healthcare 1-1 Conference and the Morgan Stanley...
Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today that it is participating in two healthcare conferences during the third quarter, the 2014 Avondale Partners Healthcare 1-1 Conference and the Morgan Stanley...
Covance Inc. (NYSE: CVD) today reported results for its second quarter ended June 30, 2014. Net revenue was $639 million, representing 8.0% growth from the second quarter of 2013. On a GAAP basis, the company reported...
Covance Inc. (NYSE: CVD) today reported results for its second quarter ended June 30, 2014. Net revenue was $639 million, representing 8.0% growth from the second quarter of 2013. On a GAAP basis, the company reported...
Regado Biosciences, Inc. (Nasdaq: RGDO), a biopharmaceutical company focused on the Phase 3 clinical development of Revolixys™ Kit (previously known as REG1), its first-in-class, actively controllable antithrombotic drug...
Regado Biosciences, Inc. (Nasdaq: RGDO), a biopharmaceutical company focused on the Phase 3 clinical development of Revolixys™ Kit (previously known as REG1), its first-in-class, actively controllable antithrombotic drug...
Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today reported total revenues of $39.8 million for the second quarter of 2014, an increase of 62% compared to revenues...
Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today reported total revenues of $39.8 million for the second quarter of 2014, an increase of 62% compared to revenues...
Sequenom, Inc. (NASDAQ: SQNM), a life sciences company that provides innovative genetic analysis solutions, and Mayo Medical Laboratories (MML), the third-largest provider of esoteric laboratory services in the United...
Sequenom, Inc. (NASDAQ: SQNM), a life sciences company that provides innovative genetic analysis solutions, and Mayo Medical Laboratories (MML), the third-largest provider of esoteric laboratory services in the United...
Pfenex Inc. (NYSE MKT: PFNX) today announced that it has closed its previously announced initial public offering of 8,333,333 shares of its common stock at a price to the public of $6.00 per share. All of the common stock...
Pfenex Inc. (NYSE MKT: PFNX) today announced that it has closed its previously announced initial public offering of 8,333,333 shares of its common stock at a price to the public of $6.00 per share. All of the common stock...
Landauer, Inc. (NYSE: LDR), a recognized leader in personal and environmental radiation measurement and monitoring, outsourced medical physics services and high quality medical consumable accessories, will release...
Landauer, Inc. (NYSE: LDR), a recognized leader in personal and environmental radiation measurement and monitoring, outsourced medical physics services and high quality medical consumable accessories, will release...
WINNIPEG, MB and MIINNEAPOLIS, MN, July 29, 2014 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM)
WINNIPEG, MB and MIINNEAPOLIS, MN, July 29, 2014 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM)
ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT: IMUC) today announced that it plans to report second quarter 2014 financial results on Thursday, August 7, 2014. ImmunoCellular will host a conference call...
ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT: IMUC) today announced that it plans to report second quarter 2014 financial results on Thursday, August 7, 2014. ImmunoCellular will host a conference call...
Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today reported net income for the quarter ended June 30, 2014 of $547.0 million, or $5.09 per...
Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today reported net income for the quarter ended June 30, 2014 of $547.0 million, or $5.09 per...
EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that it will host a conference...
EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that it will host a conference...
Human Longevity, Inc. (HLI), a genomics and cell therapy-based diagnostic and therapeutic company focused on extending the healthy, high performance human life span, today announced they have hired Franz Och, Ph.D., an...
Human Longevity, Inc. (HLI), a genomics and cell therapy-based diagnostic and therapeutic company focused on extending the healthy, high performance human life span, today announced they have hired Franz Och, Ph.D., an...
Achieved Q2 2014 targets: Adjusted net sales of $331.2 million (+4% CER); adjusted operating income of $81.2 million and 25% operating margin; adjusted EPS of $0.26 CER H1 2014 adjusted net sales rise approximately 8% CER...
Achieved Q2 2014 targets: Adjusted net sales of $331.2 million (+4% CER); adjusted operating income of $81.2 million and 25% operating margin; adjusted EPS of $0.26 CER H1 2014 adjusted net sales rise approximately 8% CER...
GSK (LSE/NYSE: GSK) today announced that once-weekly Tanzeum (albiglutide), a prescription injectable treatment for type 2 diabetes in adults, as an adjunct to diet and exercise, is now available in pharmacies throughout...
GSK (LSE/NYSE: GSK) today announced that once-weekly Tanzeum (albiglutide), a prescription injectable treatment for type 2 diabetes in adults, as an adjunct to diet and exercise, is now available in pharmacies throughout...
Centennial Medical Center has joined with United Healthcare in a three-year contract agreement to provide services to patients in the Frisco area.
Centennial Medical Center has joined with United Healthcare in a three-year contract agreement to provide services to patients in the Frisco area.
Pomerantz LLP is investigating claims on behalf of investors of Impax Laboratories, Inc. ("Impax" or the "Company") (NASDAQ: IPXL). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or...
Pomerantz LLP is investigating claims on behalf of investors of Impax Laboratories, Inc. ("Impax" or the "Company") (NASDAQ: IPXL). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or...
The Society for Clinical Research Sites (SCRS) has announced a new and updated program for the 9th annual Site Solutions Summit, October 10 – 12, 2014 in Amelia Island, Florida. The focus on collaboration between...
The Society for Clinical Research Sites (SCRS) has announced a new and updated program for the 9th annual Site Solutions Summit, October 10 – 12, 2014 in Amelia Island, Florida. The focus on collaboration between...
With acne as the most common skin condition affecting more than 60 million Americans today, it is no surprise that 20 million people have severe enough acne to cause scarring (33 percent of sufferers). Cynosure, the...
With acne as the most common skin condition affecting more than 60 million Americans today, it is no surprise that 20 million people have severe enough acne to cause scarring (33 percent of sufferers). Cynosure, the...
The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today approved $54.8 million in funding to support 33 new patient-centered comparative clinical effectiveness research (CER) projects that will...
The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today approved $54.8 million in funding to support 33 new patient-centered comparative clinical effectiveness research (CER) projects that will...
All content © Copyright 2000-2011 WorldNow and KFDA. All Rights Reserved. For more information on this site, please read our Privacy Policy and Terms of Service.
